Search research articles
Contact Us
Filters
Showing results (11-20 of 74) with videos related to
Page
of 8
Sort By:
Neurobiology of Aging
|
November 5, 2018
Key periods of cognitive decline in a nonhuman primate model of cognitive aging, the common marmoset (Callithrix jacchus)
Amirouche Sadoun, Maxime Rosito, Caroline Fonta, et al.
Clinical and Translational Science
|
September 27, 2022
Population pharmacokinetic and pharmacodynamic modeling of evobrutinib in healthy adult participants
Orestis Papasouliotis, David Mitchell, Pascal Girard, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
January 10, 2003
Clinical trial simulation using therapeutic effect modeling: application to ivabradine efficacy in patients with angina pectoris
Sylvie Chabaud, Pascal Girard, Patrice Nony, et al.
Contemporary Clinical Trials
|
December 26, 2021
Optimization of dose selection using multiple surrogates of toxicity as a continuous variable in phase I cancer trial
Se Yoon Lee, Alain Munafo, Pascal Girard, et al.
Clinical and Translational Science
|
September 20, 2022
Determination of a clinically effective evobrutinib dose: Exposure-response analyses of a phase II relapsing multiple sclerosis study
Orestis Papasouliotis, David Mitchell, Pascal Girard, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 2, 2018
Assessing Similarity Among Individual Tumor Size Lesion Dynamics: The CICIL Methodology
Nadia Terranova, Pascal Girard, Konstantinos Ioannou, et al.
Therapie
|
June 22, 2007
[Issues of the study of patient compliance to treatment with oral anticancer chemotherapy: advantages of pharmacokinetics-pharmacodynamics modelisation]
Emilie Hénin, Benoit You, Brigitte Tranchand, et al.
Cancer Chemotherapy and Pharmacology
|
April 7, 2022
Population pharmacokinetic analysis of tepotinib, an oral MET kinase inhibitor, including data from the VISION study
Wenyuan Xiong, Orestis Papasouliotis, E Niclas Jonsson, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
May 21, 2021
Fast screening of covariates in population models empowered by machine learning
Emeric Sibieude, Akash Khandelwal, Jan S Hesthaven, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
October 28, 2021
Population pharmacokinetic model selection assisted by machine learning
Emeric Sibieude, Akash Khandelwal, Pascal Girard, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 74) with videos related to
Sort By:
Page
of 8
Neurobiology of Aging
|
November 5, 2018
Key periods of cognitive decline in a nonhuman primate model of cognitive aging, the common marmoset (Callithrix jacchus)
Amirouche Sadoun, Maxime Rosito, Caroline Fonta, et al.
Clinical and Translational Science
|
September 27, 2022
Population pharmacokinetic and pharmacodynamic modeling of evobrutinib in healthy adult participants
Orestis Papasouliotis, David Mitchell, Pascal Girard, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
January 10, 2003
Clinical trial simulation using therapeutic effect modeling: application to ivabradine efficacy in patients with angina pectoris
Sylvie Chabaud, Pascal Girard, Patrice Nony, et al.
Contemporary Clinical Trials
|
December 26, 2021
Optimization of dose selection using multiple surrogates of toxicity as a continuous variable in phase I cancer trial
Se Yoon Lee, Alain Munafo, Pascal Girard, et al.
Clinical and Translational Science
|
September 20, 2022
Determination of a clinically effective evobrutinib dose: Exposure-response analyses of a phase II relapsing multiple sclerosis study
Orestis Papasouliotis, David Mitchell, Pascal Girard, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 2, 2018
Assessing Similarity Among Individual Tumor Size Lesion Dynamics: The CICIL Methodology
Nadia Terranova, Pascal Girard, Konstantinos Ioannou, et al.
Therapie
|
June 22, 2007
[Issues of the study of patient compliance to treatment with oral anticancer chemotherapy: advantages of pharmacokinetics-pharmacodynamics modelisation]
Emilie Hénin, Benoit You, Brigitte Tranchand, et al.
Cancer Chemotherapy and Pharmacology
|
April 7, 2022
Population pharmacokinetic analysis of tepotinib, an oral MET kinase inhibitor, including data from the VISION study
Wenyuan Xiong, Orestis Papasouliotis, E Niclas Jonsson, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
May 21, 2021
Fast screening of covariates in population models empowered by machine learning
Emeric Sibieude, Akash Khandelwal, Jan S Hesthaven, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
October 28, 2021
Population pharmacokinetic model selection assisted by machine learning
Emeric Sibieude, Akash Khandelwal, Pascal Girard, et al.
Page
of 8